Literature DB >> 22468085

Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers.

Nina Kočevar1, Federico Odreman, Alessandro Vindigni, Snježana Frković Grazio, Radovan Komel.   

Abstract

AIM: To search for and validate differentially expressed proteins in patients with gastric adenocarcinoma.
METHODS: We used two-dimensional gel electrophoresis and mass spectrometry to search for differentially expressed proteins in patients with gastric adenocarcinoma. A set of proteins was validated with immunoblotting.
RESULTS: We identified 30 different proteins involved in various biological processes: metabolism, development, death, response to stress, cell cycle, cell communication, transport, and cell motility. Eight proteins were chosen for further validation by immunoblotting. Our results show that gastrokine-1, 39S ribosomal protein L12 (mitochondrial precursor), plasma cell-induced resident endoplasmic reticulum protein, and glutathione S-transferase mu 3 were significantly underexpressed in gastric adenocarcinoma relative to adjacent non-tumor tissue samples. On the other hand, septin-2, ubiquitin-conjugating enzyme E2 N, and transaldolase were significantly overexpressed. Translationally controlled tumor protein was shown to be differentially expressed only in patients with cancer of the gastric cardia/esophageal border.
CONCLUSION: This work presents a set of possible diagnostic biomarkers, validated for the first time. It might contribute to the efforts of understanding gastric cancer carcinogenesis.

Entities:  

Keywords:  Biomarkers; Gastric adenocarcinoma; Mass spectrometry; Proteome; Two-dimensional gel electrophoresis

Mesh:

Substances:

Year:  2012        PMID: 22468085      PMCID: PMC3309911          DOI: 10.3748/wjg.v18.i11.1216

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  99 in total

1.  Overexpression of cathepsin B in gastric cancer identified by proteome analysis.

Authors:  Matthias P A Ebert; Sabine Krüger; Marie-Laure Fogeron; Stephanie Lamer; Jie Chen; Matthias Pross; Hans-Ulrich Schulz; Hermann Lage; Steffen Heim; Albert Roessner; Peter Malfertheiner; Christoph Röcken
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

2.  Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma.

Authors:  Rachel A Craven; Sarah Hanrahan; Nick Totty; Patricia Harnden; Anthea J Stanley; Eamonn R Maher; Adrian L Harris; William S Trimble; Peter J Selby; Rosamonde E Banks
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

3.  Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.

Authors:  Christian Melle; Günther Ernst; Bettina Schimmel; Annett Bleul; Roland Kaufmann; Merten Hommann; Konrad K Richter; Wolfgang Daffner; Utz Settmacher; Uwe Claussen; Ferdinand von Eggeling
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

4.  Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.

Authors:  Carmen Martínez; Felipe Martín; Juana M Fernández; Elena García-Martín; Javier Sastre; Manuel Díaz-Rubio; José Ag Agúndez; José M Ladero
Journal:  Pharmacogenomics       Date:  2006-07       Impact factor: 2.533

5.  Characterization of fortilin, a novel antiapoptotic protein.

Authors:  F Li; D Zhang; K Fujise
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

6.  Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.

Authors:  R M Hofmann; C M Pickart
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

7.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.

Authors:  Catharine M Sturgeon; Michael J Duffy; Barry R Hofmann; Rolf Lamerz; Herbert A Fritsche; Katja Gaarenstroom; Johannes Bonfrer; Thorsten H Ecke; H Barton Grossman; Peter Hayes; Ralf-Thorsten Hoffmann; Seth P Lerner; Florian Löhe; Johanna Louhimo; Ihor Sawczuk; Kazuhisa Taketa; Eleftherios P Diamandis
Journal:  Clin Chem       Date:  2010-03-05       Impact factor: 8.327

8.  Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.

Authors:  K Banki; E Hutter; E Colombo; N J Gonchoroff; A Perl
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

9.  Novel breast cancer metastasis-associated proteins.

Authors:  Jiapei Ho; Jacklyn-Wai-Fun Kong; Lee-Yee Choong; Marie-Chiew-Shia Loh; Weiyi Toy; Poh-Kuan Chong; Chee-Hong Wong; Chow-Yin Wong; Nilesh Shah; Yoon-Pin Lim
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

10.  Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.

Authors:  K Banki; E Colombo; F Sia; D Halladay; D H Mattson; A H Tatum; P T Massa; P E Phillips; A Perl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  9 in total

Review 1.  What gastric cancer proteomic studies show about gastric carcinogenesis?

Authors:  Mariana Ferreira Leal; Fernanda Wisnieski; Carolina de Oliveira Gigek; Leonardo Caires do Santos; Danielle Queiroz Calcagno; Rommel Rodriguez Burbano; Marilia Cardoso Smith
Journal:  Tumour Biol       Date:  2016-04-28

2.  Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.

Authors:  Elizabeth A Marcus; Elmira Tokhtaeva; Shahlo Turdikulova; Joseph Capri; Julian P Whitelegge; David R Scott; George Sachs; Fedor Berditchevski; Olga Vagin
Journal:  Biochem J       Date:  2016-04-05       Impact factor: 3.857

3.  Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia.

Authors:  Ana Jeromen; Irena Oblak; Franc Anderluh; Vaneja Velenik; Marija Skoblar Vidmar; Ivica Ratoša
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

4.  Expression of septin 2 and association with clinicopathological parameters in colorectal cancer.

Authors:  Haoyu He; Junjun Li; Meng Xu; Ziliang Kan; Yang Gao; Caijun Yuan
Journal:  Oncol Lett       Date:  2019-06-26       Impact factor: 2.967

Review 5.  The Role of the Pentose Phosphate Pathway in Diabetes and Cancer.

Authors:  Tongxin Ge; Jiawen Yang; Shihui Zhou; Yuchen Wang; Yakui Li; Xuemei Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-09       Impact factor: 5.555

6.  Proteomic Analysis Reveals Molecular Differences in the Development of Gastric Cancer.

Authors:  Rinchen Dhondrup; XiaoKang Zhang; Xuemei Feng; Dhondrup Lobsang; Qincuo Hua; Junli Liu; Ying Cuo; Sangji Zhuoma; Geri Duojie; Suonan Duojie Caidan; Samdrup Gyal
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-31       Impact factor: 2.650

Review 7.  Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.

Authors:  Petra Hudler; Nina Kocevar; Radovan Komel
Journal:  ScientificWorldJournal       Date:  2014-01-14

8.  Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.

Authors:  Peng Dai; Qin Wang; Weihua Wang; Ruirui Jing; Wei Wang; Fengqin Wang; Kazem M Azadzoi; Jing-Hua Yang; Zhen Yan
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

Review 9.  Impact of proteomics investigations on gastric cancer treatment and diagnosis.

Authors:  Mohammad Rostami-Nejad; Mostafa Rezaei-Tavirani; Vahid Mansouri; Zahra Akbari; Saeed Abdi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.